Published in N Engl J Med on December 21, 2006
Clinical and Biological Markers in Acute Respiratory Failure | NCT02019095
Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med (2008) 9.68
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet (2010) 6.07
Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet (2008) 5.49
Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis (2011) 5.34
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol (2010) 3.23
Beyond odds ratios--communicating disease risk based on genetic profiles. Nat Rev Genet (2009) 3.01
Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ (2009) 3.00
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol (2008) 2.79
Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol (2009) 2.77
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study. Lancet Oncol (2012) 2.31
Prediction of HIV acquisition among men who have sex with men. Sex Transm Dis (2009) 2.26
Physical capability in mid-life and survival over 13 years of follow-up: British birth cohort study. BMJ (2014) 2.24
Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest (2009) 2.17
Prostate cancer genomics: towards a new understanding. Nat Rev Genet (2008) 2.08
Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med (2011) 2.03
Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation (2011) 1.77
Predictors of the risk of cognitive deficiency in very preterm infants: the EPIPAGE prospective cohort. Acta Paediatr (2011) 1.75
Genome-wide association studies and beyond. Annu Rev Public Health (2010) 1.73
A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med (2012) 1.70
Cardiovascular risk assessment scores for people with diabetes: a systematic review. Diabetologia (2009) 1.65
Validation of biomarker-based risk prediction models. Clin Cancer Res (2008) 1.57
Calibrating parametric subject-specific risk estimation. Biometrika (2010) 1.54
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening. Urology (2010) 1.53
Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am J Physiol Lung Cell Mol Physiol (2008) 1.46
Predicting heart failure hospitalization and mortality by quantitative echocardiography: is body surface area the indexing method of choice? The Heart and Soul Study. J Am Soc Echocardiogr (2010) 1.42
Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes (2009) 1.31
Erectile function and risk of Parkinson's disease. Am J Epidemiol (2007) 1.15
Early identification of cardiovascular risk using genomics and proteomics. Nat Rev Cardiol (2010) 1.14
Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative. CMAJ (2011) 1.12
Conceptual problems in laypersons' understanding of individualized cancer risk: a qualitative study. Health Expect (2009) 1.12
Authorship bias in violence risk assessment? A systematic review and meta-analysis. PLoS One (2013) 1.12
The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med (2010) 1.08
A new electrocardiogram marker to identify patients at low risk for ventricular tachyarrhythmias: sum magnitude of the absolute QRST integral. J Electrocardiol (2010) 1.07
Assessing the Incremental Role of Novel and Emerging Risk Factors. Curr Cardiovasc Risk Rep (2010) 1.04
The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population. Curr Atheroscler Rep (2011) 1.02
Non-parametric Evaluation of Biomarker Accuracy under Nested Case-control Studies. J Am Stat Assoc (2012) 1.01
Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves. Curr Opin HIV AIDS (2010) 1.01
Biomarkers in peripheral arterial disease patients and near- and longer-term mortality. J Vasc Surg (2010) 1.00
Assessing risk for development of diabetes in young adults. Ann Fam Med (2007) 1.00
Implementing frailty into clinical practice: a cautionary tale. J Gerontol A Biol Sci Med Sci (2013) 1.00
Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III). BMC Nephrol (2012) 0.99
Chapter 12: systematic review of prognostic tests. J Gen Intern Med (2012) 0.98
Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ. BMC Pulm Med (2012) 0.97
Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vision Res (2009) 0.95
Ascites improves upon [corrected] serum sodium plus [corrected] model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease. Aliment Pharmacol Ther (2009) 0.95
Framingham risk prediction equations for incidence of cardiovascular disease using detailed measures for smoking. Heart Int (2010) 0.93
Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative. Arterioscler Thromb Vasc Biol (2014) 0.92
Comparison of estimated glomerular filtration rates and albuminuria in predicting risk of coronary heart disease in a population with high prevalence of diabetes mellitus and renal disease. Am J Cardiol (2011) 0.91
Scaling up chronic disease prevention interventions in lower- and middle-income countries. Annu Rev Public Health (2013) 0.91
Assessment of the value of a genetic risk score in improving the estimation of coronary risk. Atherosclerosis (2012) 0.91
Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction. Funct Integr Genomics (2010) 0.90
Biomarkers and cardiovascular risk assessment for primary prevention: an update. Clin Chem (2011) 0.89
Cardiovascular risk assessment: addition of CKD and race to the Framingham equation. Am Heart J (2012) 0.87
Evaluation of prediction models for decision-making: beyond calibration and discrimination. PLoS Med (2013) 0.87
Graphical procedures for evaluating overall and subject-specific incremental values from new predictors with censored event time data. Biometrics (2011) 0.86
MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study. BMC Cancer (2013) 0.86
Patient-controlled encrypted genomic data: an approach to advance clinical genomics. BMC Med Genomics (2012) 0.85
Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling. J Clin Invest (2008) 0.85
A predictive model combining fecal calgranulin B and fecal occult blood tests can improve the diagnosis of colorectal cancer. PLoS One (2014) 0.84
Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction. BMC Med Genomics (2011) 0.84
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators. J Biomed Inform (2015) 0.84
Biomarkers of atherosclerosis: clinical applications. Curr Cardiol Rep (2008) 0.83
Translating associations between common kidney diseases and genetic variation into the clinic. Semin Nephrol (2010) 0.82
Big data for bipolar disorder. Int J Bipolar Disord (2016) 0.82
The relationship between cord blood immunoglobulin E levels and allergy-related outcomes in young adults. Ann Allergy Asthma Immunol (2011) 0.82
Overview of data-synthesis in systematic reviews of studies on outcome prediction models. BMC Med Res Methodol (2013) 0.82
Biobanking in atherosclerotic disease, opportunities and pitfalls. Curr Cardiol Rev (2011) 0.82
Biomarkers in kidney fibrosis: are they useful? Kidney Int Suppl (2011) (2014) 0.81
Targeted Local Support Vector Machine for Age-Dependent Classification. J Am Stat Assoc (2014) 0.81
A common polymorphism in NR1H2 (LXRbeta) is associated with preeclampsia. BMC Med Genet (2011) 0.80
The diagnosis of colorectal cancer in patients with symptoms: finding a needle in a haystack. BMC Med (2009) 0.80
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss. J Am Soc Nephrol (2016) 0.79
Understanding increments in model performance metrics. Lifetime Data Anal (2012) 0.79
Proposals for enhanced health risk assessment and stratification in an integrated care scenario. BMJ Open (2016) 0.79
Defining and predicting severe community-acquired pneumonia. Curr Opin Infect Dis (2010) 0.78
Defining severe pneumonia. Clin Chest Med (2011) 0.77
Diminished renal function and the incidence of heart failure. Curr Cardiol Rev (2009) 0.77
Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons. Curr Cardiovasc Risk Rep (2010) 0.77
A moderator-mediator analysis of coronary heart disease mortality. J Psychosom Res (2010) 0.77
Age at quitting smoking as a predictor of risk of cardiovascular disease incidence independent of smoking status, time since quitting and pack-years. BMC Res Notes (2011) 0.77
Evaluating the improvement in diagnostic utility from adding new predictors. Biom J (2010) 0.77
Primary prevention of heart failure. ISRN Cardiol (2012) 0.76
Landmark risk prediction of residual life for breast cancer survival. Stat Med (2013) 0.76
Urinary tract infection in primary care. BMJ (2007) 0.76
Recalibration and validation of the Charlson comorbidity index in Korean incident hemodialysis patients. PLoS One (2015) 0.76
Wheel running, skeletal muscle aerobic capacity and 1-methyl-1-nitrosourea induced mammary carcinogenesis in the rat. Carcinogenesis (2010) 0.76
The public health utility of genome-wide association study results for smoking behavior. Genome Med (2010) 0.75
Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge? Int J Epidemiol (2016) 0.75
Biomarkers for prediction of cardiovascular events. N Engl J Med (2007) 0.75
Physical Health Indicators Improve Prediction of Cardiovascular and All-cause Mortality among Middle-Aged and Older People: a National Population-based Study. Sci Rep (2017) 0.75
Molecular gene signature and prognosis of non-small cell lung cancer. Oncotarget (2016) 0.75
Assessment of the Importance of a New Risk Factor in Prediction Models. Iran Red Crescent Med J (2016) 0.75
Biomarkers for prediction of cardiovascular events. N Engl J Med (2007) 0.75
The Use of a Bayesian Hierarchy to Develop and Validate a Co-Morbidity Score to Predict Mortality for Linked Primary and Secondary Care Data from the NHS in England. PLoS One (2016) 0.75
Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers. Trends Cardiovasc Med (2016) 0.75
Development and validation of a clinical score for prognosis stratification in patients requiring antiretroviral therapy in sub-Saharan Africa: a prospective open cohort study. Pan Afr Med J (2011) 0.75
The Effectiveness of Sanitary Inspections as a Risk Assessment Tool for Thermotolerant Coliform Bacteria Contamination of Rural Drinking Water: A Review of Data from West Bengal, India. Am J Trop Med Hyg (2017) 0.75
Predicting late-onset sepsis by routine neonatal screening for colonisation by gram-negative bacteria in neonates at intensive care units: a protocol for a systematic review. BMJ Open (2017) 0.75
Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60
Pragmatic trials--guides to better patient care? N Engl J Med (2011) 3.11